| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1151088B1 Improved phytases |
| 08/30/2006 | EP1147124B1 Steroid sulfatase inhibitors and methods for making and using the same |
| 08/30/2006 | EP1066042B1 Steroidal saponins for treating alzheimer's disease |
| 08/30/2006 | EP1037900A4 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/30/2006 | EP1020439B1 Cetp activity inhibitors |
| 08/30/2006 | CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use |
| 08/30/2006 | CN1826140A Combination therapy for the treatment of bacterial infections |
| 08/30/2006 | CN1824664A Novel quinuclidine derivatives and medicinal compositions containing the same |
| 08/30/2006 | CN1824317A Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 08/30/2006 | CN1824311A Preparation for the prophylaxis of restenosis |
| 08/30/2006 | CN1824301A Purified ustading and its preparation method and medicinal composition containing said ustading |
| 08/30/2006 | CN1824283A Medicine and food dual purpose Chinese medicinal product for preventing and treating lethargy and its manufacturing method |
| 08/30/2006 | CN1824272A Alpinia eye brightening drink and its manufacturing method |
| 08/30/2006 | CN1824251A Chinese medicinal plaster of infrared energy ceramic powder for promoting blood circulation and its preparation method |
| 08/30/2006 | CN1824250A Quality control method of scourge repelling capsule |
| 08/30/2006 | CN1824235A Medicine and food dual purpose Chinese medicinal product for antifatigue and its manufacturing method |
| 08/30/2006 | CN1824226A Chinese medicinal preparation for improving memory and its preparation method |
| 08/30/2006 | CN1824223A Medicine and food dual purpose Chinese medicinal product for preventing and treating weak lumbus and legs and its manufacturing method |
| 08/30/2006 | CN1824200A Medicine and food dual purpose Chinese medicine for preventing and treating summer heat damp diarrhea and its manufacturing method |
| 08/30/2006 | CN1824140A Anemarrhena, phello dendron and rehmannia fast dispersion solid medicinal preparation and its manufacturing method |
| 08/30/2006 | CN1824120A Oral liquid capable of raising human body anoxia tolerance and its preparation method |
| 08/30/2006 | CN1824085A Edible health protection product possessing auxiliary improving function and physical strength fatigue delaying function |
| 08/30/2006 | CN1824079A Anti appendicitis preparation and its new preparation method |
| 08/30/2006 | CN1824026A Chinese medicine for improving memory and its preparation method |
| 08/30/2006 | CN1823987A Application of coptic toxin resolving decoction in preparation of medicine for predventing and treating tumour chemotherapy tolerance |
| 08/30/2006 | CN1823984A Pushi granule and its preparation technology |
| 08/30/2006 | CN1823970A Medicine and food dual purpose Chinese medicinal product for preventing and treating red eye, aversion to light and its manufacturing method |
| 08/30/2006 | CN1823966A Medicine for treating aurigo |
| 08/30/2006 | CN1823950A Disinfecting anti inflammatory pain relieving spirit raising brain arousing medicinal oil |
| 08/30/2006 | CN1823949A Disinfecting pain relieving heat dispersing spirit raising medicinal liquid |
| 08/30/2006 | CN1823933A Ginseng aconite injection liquid and its preparation method |
| 08/30/2006 | CN1823905A Medicine for treating heatstroke and its preparation method |
| 08/30/2006 | CN1823861A Preparation technology of metaplexis and rostellularia extract |
| 08/30/2006 | CN1823855A Preparation method of yellow gumbo freeze dried powder |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823746A Compound formula mannitol injection liquid |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/30/2006 | CN1272334C Quinuclidine derivs. as muscarinic M3 receptors ligand and their use |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272045C Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/30/2006 | CN1272007C Compound formulation for preventing and treating broiler ascites syndrome |
| 08/30/2006 | CN1271987C Health-preserving liquor with functions of making human body weightless and relaxing muscle |
| 08/30/2006 | CN1271955C Beverage prescription with glutinous rehmannia as main material |
| 08/30/2006 | CN1271945C Composition of ganglioside and bean food and its application |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098364 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis |
| 08/29/2006 | US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | US7098333 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098308 Pentapeptide compounds and uses related thereto |
| 08/29/2006 | US7098305 Sustained release of microcrystalline peptide suspensions |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098237 administering type II sPLA2 inhibitor such as 2-[[3-(2-amino-2-oxoethyl)-2-ethyl-1-(1-naphthyl)methylene-1H-indene-4-yl]oxy]acetic acid |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098228 Indolyl derivatives |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098224 Treating psoriasis, gastroesophageal reflux, Zollinger-Ellison Syndrome; antiulcer and antisecretory agents |
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098204 Hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7098192 Antisense oligonucleotide modulation of STAT3 expression |
| 08/29/2006 | US7098190 Formulations comprising antisense nucleotides to connexins |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7097998 Aβ42 lowering agents |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097977 Target of anticancer agent |
| 08/29/2006 | US7097851 Multilayer capsule comprises an adhesion site-controlling layer for attaching to a selected site in the intestines, a drug-carrying layer, a protecting layer for preventing from digestive juice; improve bioavailability due to a low absorption in the digestive tract; dosage forms |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/29/2006 | CA2268195C Azaheterocyclylmethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006088229A1 Modified virus capsid protein and the use thereof |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088188A1 Oil-and-fat composition |
| 08/24/2006 | WO2006088173A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity |
| 08/24/2006 | WO2006088129A1 Salt of proline derivative, solvate thereof, and production method thereof |
| 08/24/2006 | WO2006088080A1 CYCLOHEPTA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006088017A1 Sugar chain containing 4-position halogenated galactose and application thereof |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |